Mabvax Therapeutics Holdings, Inc.

CIK 1109196 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mabvax Therapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Sep 19, 2019RW0001654954-19-010913
May 9, 2019SC 13G/A0001193125-19-143158
Apr 24, 201910-Q/A0001654954-19-004708
Apr 22, 2019SEC STAFF ACTION9999999997-19-003119
Apr 22, 2019SEC STAFF ACTION9999999997-19-003118
Apr 22, 2019SEC STAFF ACTION9999999997-19-003120
Apr 22, 2019SEC STAFF ACTION9999999997-19-003117
Mar 29, 201915-12G0001654954-19-003702
Mar 29, 201910-Q/A0001654954-19-003644
Mar 25, 20198-K0001654954-19-003258
Jan 4, 20198-K0001654954-19-000099
Nov 20, 2018S-10001654954-18-013055
Nov 20, 20188-K0001654954-18-013052
Nov 13, 201810-Q0001654954-18-012555
Oct 22, 2018CT ORDER9999999997-18-008764
Oct 22, 20188-K0001654954-18-011417
Oct 16, 20188-K0001654954-18-011206
Oct 15, 201810-K/A0001654954-18-011102
Oct 15, 201810-Q0001654954-18-011103
Oct 15, 201810-Q0001654954-18-011104
Sep 27, 201825-NSE0001354457-18-000381
Aug 6, 2018SC 13G0001493152-18-011029
Jul 25, 2018SC 13D/A0001493152-18-010411
Jul 9, 20188-K0001415889-18-001093
Jul 5, 20188-K0001654954-18-007372